Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differential Diagnosis of Renal Tumors With Clear Cytoplasm: Clinical Relevance of Renal Tumor Subclassification in the Era of Targeted Therapies and Personalized Medicine
Rajen Goyal, Elizabeth Gersbach, Ximing J. Yang, et al.
Archives of Pathology & Laboratory Medicine (2013) Vol. 137, Iss. 4, pp. 467-480
Closed Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies
Peter Makhov, Shreyas Joshi, Pooja Ghatalia, et al.
Molecular Cancer Therapeutics (2018) Vol. 17, Iss. 7, pp. 1355-1364
Open Access | Times Cited: 412
Pan-Renal Cell Carcinoma classification and survival prediction from histopathology images using deep learning
Sairam Tabibu, P. K. Vinod, C. V. Jawahar
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 198
Renal Cell Cancer – Insights in Drug Resistance Mechanisms
HALIMA AWEYS, DEISHA LEWIS, Matin Sheriff, et al.
Anticancer Research (2023) Vol. 43, Iss. 11, pp. 4781-4792
Open Access | Times Cited: 30
LncRNA MILIP links YBX1 to translational activation of Snai1 and promotes metastasis in clear cell renal cell carcinoma
Yanliang Wang, Yuchen Feng, Yujin Gan, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 28
Automated clear cell renal carcinoma grade classification with prognostic significance
Katherine Tian, Christopher A. Rubadue, Douglas I. Lin, et al.
PLoS ONE (2019) Vol. 14, Iss. 10, pp. e0222641-e0222641
Open Access | Times Cited: 47
<p>Co-delivery of everolimus and vinorelbine via a tumor-targeted liposomal formulation inhibits tumor growth and metastasis in RCC</p>
Krishnendu Pal, Vijay Sagar Madamsetty, Shamit K. Dutta, et al.
International Journal of Nanomedicine (2019) Vol. Volume 14, pp. 5109-5123
Open Access | Times Cited: 44
B7-H3 expression is associated with high PD-L1 expression in clear cell renal cell carcinoma and predicts poor prognosis
Jung Hee Lee, Yong Jun Kim, Hyun Woo Ryu, et al.
Diagnostic Pathology (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 13
A comprehensive simulation study on classification of RNA-Seq data
Gökmen Zararsız, Dinçer Göksülük, Selçuk Korkmaz, et al.
PLoS ONE (2017) Vol. 12, Iss. 8, pp. e0182507-e0182507
Open Access | Times Cited: 42
Synchronous inhibition of mTOR and VEGF/NRP1 axis impedes tumor growth and metastasis in renal cancer
Krishnendu Pal, Vijay Sagar Madamsetty, Shamit K. Dutta, et al.
npj Precision Oncology (2019) Vol. 3, Iss. 1
Open Access | Times Cited: 38
RNA-binding protein IGF2BP2 suppresses metastasis of clear cell renal cell carcinoma by enhancing CKB mRNA stability and expression
Junwu Ren, Bo Huang, Wei Li, et al.
Translational Oncology (2024) Vol. 42, pp. 101904-101904
Open Access | Times Cited: 4
Machine learning-driven prognostic analysis of cuproptosis and disulfidptosis-related lncRNAs in clear cell renal cell carcinoma: a step towards precision oncology
Ronghui Chen, Jun Wu, Yinwei Che, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 4
Frontiers in Clinical and Molecular Diagnostics and Staging of Metastatic Clear Cell Renal Cell Carcinoma
Anna M. Czarnecka, Anna Kornakiewicz, Wojciech Kukwa, et al.
Future Oncology (2014) Vol. 10, Iss. 6, pp. 1095-1111
Open Access | Times Cited: 36
Immunohistochemical Panel for Differentiating Renal Cell Carcinoma with Clear and Papillary Features
Hanan AlSaeid Alshenawy
Pathology & Oncology Research (2015) Vol. 21, Iss. 4, pp. 893-899
Closed Access | Times Cited: 33
The Application of Immunohistochemical Biomarkers in Urologic Surgical Pathology
Myra L. Wilkerson, Fan Lin, Haiyan Liu, et al.
Archives of Pathology & Laboratory Medicine (2014) Vol. 138, Iss. 12, pp. 1643-1665
Closed Access | Times Cited: 31
Phospho-4e-BP1 and eIF4E overexpression synergistically drives disease progression in clinically confined clear cell renal cell carcinoma.
Lee Ann Campbell, Bharat Jasani, David F. Griffiths, et al.
PubMed (2015) Vol. 5, Iss. 9, pp. 2838-48
Closed Access | Times Cited: 26
Clear cell papillary renal cell carcinoma is an indolent and low‐grade neoplasm with overexpression of cyclin‐D1
Xavier Leroy, Philippe Camparo, Viviane Gnemmi, et al.
Histopathology (2014) Vol. 64, Iss. 7, pp. 1032-1036
Closed Access | Times Cited: 25
Transcription factor NFYA promotes G1/S cell cycle transition and cell proliferation by transactivating cyclin D1 and CDK4 in clear cell renal cell carcinoma.
Yu Li, Xing Xiao, Hengxing Chen, et al.
PubMed (2020) Vol. 10, Iss. 8, pp. 2446-2463
Closed Access | Times Cited: 21
TROAP Promotes the Proliferation, Migration, and Metastasis of Kidney Renal Clear Cell Carcinoma with the Help of STAT3
Jun Wang, Hongyuan Wan, Yuanyuan Mi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9658-9658
Open Access | Times Cited: 7
voomDDA: discovery of diagnostic biomarkers and classification of RNA-seq data
Gökmen Zararsız, Dinçer Göksülük, Bernd Klaus, et al.
PeerJ (2017) Vol. 5, pp. e3890-e3890
Open Access | Times Cited: 22
A Collision Tumor of Papillary Renal Cell Carcinoma and Oncocytoma: Case Report and Literature Review
Rajen Goyal, Anil V. Parwani, Lan L. Gellert, et al.
American Journal of Clinical Pathology (2015) Vol. 144, Iss. 5, pp. 811-816
Open Access | Times Cited: 21
Curcumin Inhibits Vasculogenic Mimicry Via Regulating ETS-1 in Renal Cell Carcinoma
Yue Chong, Shan Xu, Tianjie Liu, et al.
Current Cancer Drug Targets (2024) Vol. 24, Iss. 10, pp. 1031-1046
Closed Access | Times Cited: 2
Molecular mechanism of ferroptosis and its application in the treatment of clear cell renal cell carcinoma
Beifen pan, Jia-li Kang, Rongxin Zheng, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155324-155324
Closed Access | Times Cited: 2
Immunohistochemical panel for differentiating renal cell carcinoma with clear and papillary features
Hanan AlSaeid Alshenawy
Journal of Microscopy and Ultrastructure (2015) Vol. 3, Iss. 2, pp. 68-74
Open Access | Times Cited: 19
Integrating Phenotypic Search and Phosphoproteomic Profiling of Active Kinases for Optimization of Drug Mixtures for RCC Treatment
Judy R. van Beijnum, Andrea Weiss, Robert H. Berndsen, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2697-2697
Open Access | Times Cited: 18
Histologic Diagnosis of Renal Mass Biopsy
Steven S. Shen, Jae Y. Ro
Archives of Pathology & Laboratory Medicine (2019) Vol. 143, Iss. 6, pp. 705-710
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top